Cargando…
Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence
Hormone receptor positivity and early stage diagnosis are generally considered signs of good prognosis in breast cancer. However, breast cancer all too frequently can become resistant to hormone-based therapies, and women can experience recurrence of their breast cancer decades after the diagnosis o...
Autor principal: | Gillespie, Theresa Wicklin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517768/ https://www.ncbi.nlm.nih.gov/pubmed/33542852 http://dx.doi.org/10.6004/jadpro.2020.11.1.5 |
Ejemplares similares
-
Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence
Publicado: (2020) -
Do the Right Study: Quality Improvement Projects and Human Subject Research—Both Valuable, Simply Different
por: Gillespie, Theresa Wicklin
Publicado: (2018) -
Promising oncolytic agents for metastatic breast cancer treatment
por: Cody, James J, et al.
Publicado: (2015) -
Impact of pharmacy channel on adherence to oral oncolytics
por: Stokes, Michael, et al.
Publicado: (2017) -
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
por: Kwan, Amy, et al.
Publicado: (2021)